Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells

Elizabeth M. Hiltbold, Pawel Ciborowski, Olivera J. Finn

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Epithelial cell mucin MUC1 is expressed on adenocarcinomas in an underglycosylated form that serves as a tumor antigen in breast, pancreatic, ovarian, and other tumors. Two predominant MUC1-specific immune responses are found in patients: CD8+ CTLs, which recognize tandemly repeated epitopes on the MUC1 protein core, and IgM antibodies. There have been no reports to date of MUC1-specific CD4+ T-helper cells in cancer patients. We show here that MUC1-specific CD4+ T cells are neither deleted nor tolerized and that CD4+ T cell responses can be generated when an appropriate soluble form of MUC1 is used. Naive CD4+ T cells from healthy donors were primed in vitro to a synthetic MUC1 peptide of 100 amino acids, representing five unglycosylated tandem repeats, presented by dendritic cells. They produced IFN-γ and had moderate cytolytic activity. We identified one core peptide sequence, PGSTAPPAHGVT, that elicits; this response when it is presented by HLA-DR3.

Original languageEnglish (US)
Pages (from-to)5066-5070
Number of pages5
JournalCancer Research
Volume58
Issue number22
StatePublished - Nov 15 1998

Fingerprint

Neoplasm Antigens
Epitopes
T-Lymphocytes
HLA-DR3 Antigen
Peptides
Tandem Repeat Sequences
Mucins
Helper-Inducer T-Lymphocytes
Dendritic Cells
Immunoglobulin M
Neoplasms
Adenocarcinoma
Breast
Epithelial Cells
Tissue Donors
Amino Acids
Antibodies
Proteins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells. / Hiltbold, Elizabeth M.; Ciborowski, Pawel; Finn, Olivera J.

In: Cancer Research, Vol. 58, No. 22, 15.11.1998, p. 5066-5070.

Research output: Contribution to journalArticle

Hiltbold, Elizabeth M. ; Ciborowski, Pawel ; Finn, Olivera J. / Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells. In: Cancer Research. 1998 ; Vol. 58, No. 22. pp. 5066-5070.
@article{5cf6cdf6deb9418ab9bd9ad0e979b398,
title = "Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells",
abstract = "Epithelial cell mucin MUC1 is expressed on adenocarcinomas in an underglycosylated form that serves as a tumor antigen in breast, pancreatic, ovarian, and other tumors. Two predominant MUC1-specific immune responses are found in patients: CD8+ CTLs, which recognize tandemly repeated epitopes on the MUC1 protein core, and IgM antibodies. There have been no reports to date of MUC1-specific CD4+ T-helper cells in cancer patients. We show here that MUC1-specific CD4+ T cells are neither deleted nor tolerized and that CD4+ T cell responses can be generated when an appropriate soluble form of MUC1 is used. Naive CD4+ T cells from healthy donors were primed in vitro to a synthetic MUC1 peptide of 100 amino acids, representing five unglycosylated tandem repeats, presented by dendritic cells. They produced IFN-γ and had moderate cytolytic activity. We identified one core peptide sequence, PGSTAPPAHGVT, that elicits; this response when it is presented by HLA-DR3.",
author = "Hiltbold, {Elizabeth M.} and Pawel Ciborowski and Finn, {Olivera J.}",
year = "1998",
month = "11",
day = "15",
language = "English (US)",
volume = "58",
pages = "5066--5070",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells

AU - Hiltbold, Elizabeth M.

AU - Ciborowski, Pawel

AU - Finn, Olivera J.

PY - 1998/11/15

Y1 - 1998/11/15

N2 - Epithelial cell mucin MUC1 is expressed on adenocarcinomas in an underglycosylated form that serves as a tumor antigen in breast, pancreatic, ovarian, and other tumors. Two predominant MUC1-specific immune responses are found in patients: CD8+ CTLs, which recognize tandemly repeated epitopes on the MUC1 protein core, and IgM antibodies. There have been no reports to date of MUC1-specific CD4+ T-helper cells in cancer patients. We show here that MUC1-specific CD4+ T cells are neither deleted nor tolerized and that CD4+ T cell responses can be generated when an appropriate soluble form of MUC1 is used. Naive CD4+ T cells from healthy donors were primed in vitro to a synthetic MUC1 peptide of 100 amino acids, representing five unglycosylated tandem repeats, presented by dendritic cells. They produced IFN-γ and had moderate cytolytic activity. We identified one core peptide sequence, PGSTAPPAHGVT, that elicits; this response when it is presented by HLA-DR3.

AB - Epithelial cell mucin MUC1 is expressed on adenocarcinomas in an underglycosylated form that serves as a tumor antigen in breast, pancreatic, ovarian, and other tumors. Two predominant MUC1-specific immune responses are found in patients: CD8+ CTLs, which recognize tandemly repeated epitopes on the MUC1 protein core, and IgM antibodies. There have been no reports to date of MUC1-specific CD4+ T-helper cells in cancer patients. We show here that MUC1-specific CD4+ T cells are neither deleted nor tolerized and that CD4+ T cell responses can be generated when an appropriate soluble form of MUC1 is used. Naive CD4+ T cells from healthy donors were primed in vitro to a synthetic MUC1 peptide of 100 amino acids, representing five unglycosylated tandem repeats, presented by dendritic cells. They produced IFN-γ and had moderate cytolytic activity. We identified one core peptide sequence, PGSTAPPAHGVT, that elicits; this response when it is presented by HLA-DR3.

UR - http://www.scopus.com/inward/record.url?scp=0032534067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032534067&partnerID=8YFLogxK

M3 - Article

C2 - 9823312

AN - SCOPUS:0032534067

VL - 58

SP - 5066

EP - 5070

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 22

ER -